Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Sept 2026 for Tandem Diabetes Care, Inc., €5,506.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Novara: trading record in brief
Mark Novara discloses dealings in Tandem Diabetes Care Inc to SEC (Form 4). The record holds 3 filings, for trades running from 17 June 2026 to 17 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 17 September 2026: a transaction of €5,506, in Tandem Diabetes Care Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Novara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
360 shares@ US$17.53CommonSEC144:0001950047-26-009635
131 shares@ US$22.2550.0001% mcap32.5% of flowCommonSEC144:0001950047-26-008325
361 shares@ US$16.69100.0% of flowCommonSEC144:0001950047-26-006260
3 of 3 declarations
